Conquering cancer requires information and dialogue. Our print and online resources make it easy to stay up-to-date on CRI’s role in helping to advance cancer immunotherapy research and treatment. We also offer information especially for patients and their families, as well as for current and prospective donors.
For the latest news, sign up for our e-alerts or subscribe to our blog. You can also read our print publications, view our videos, and access our guides and other resources for patients for more information. If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
Our blog features the latest updates from the front lines of cancer immunotherapy, including new scientific and clinical breakthroughs, news stories, and program announcements. Read the latest stories here or go to our blog to see all of our posts and subscribe to receive alerts when new stories are posted.
November 24, 2015
| Arthur Brodsky
New hope now exists for patients with advanced kidney cancer.
FDA approval, kidney cancer
November 20, 2015
| Alexandra Mulvey
Daratumumab (Darzalex®) is the first approved immunotherapy that targets CD38—a protein found in most multiple myeloma cells.
November 19, 2015
| Katherine McCluskey
Thanks to our donors, we won second place in the Revlon LOVE IS ON Million Dollar Challenge.